Sean Ainsworth

Insider Reports History

Location
Farmington Hills, MI
Signature
/s/ Amy Rabourn, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sean Ainsworth:

Company Role Class Num Shares Value Price $ Report Date Ownership
Opus Genetics, Inc. Director Common Stock 297,325 $674,927 $2.27 01 Jan 2026 Direct
Opus Genetics, Inc. Director Stock Option (Right to Buy) 79,592 30 Apr 2025 Direct

Insider Reports Filed by Sean Ainsworth

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IRD Opus Genetics, Inc. 01 Jan 2026 1 $0 4 Director 05 Jan 2026, 16:21
IRD Opus Genetics, Inc. 25 Aug 2025 1 +$99,999 4 Director 27 Aug 2025, 16:13
IRD Opus Genetics, Inc. 30 Apr 2025 2 $0 4 Director 02 May 2025, 17:02
IRD Ocuphire Pharma, Inc. 11 Jun 2024 2 $0 4 Director 13 Jun 2024, 17:23
IRD Ocuphire Pharma, Inc. 06 Jun 2023 2 $0 4 Director 08 Jun 2023, 18:49
IRD Ocuphire Pharma, Inc. 31 Dec 2022 1 $0 5 Director 14 Feb 2023, 13:03
IRD Ocuphire Pharma, Inc. 19 Oct 2022 2 +$0.1574 4 Director 20 Oct 2022, 16:01
IRD Ocuphire Pharma, Inc. 13 Jun 2022 1 $0 4 Director 15 Jun 2022, 16:01
IRD Ocuphire Pharma, Inc. 31 Dec 2021 1 $0 5 Director 14 Feb 2022, 08:17
IRD Ocuphire Pharma, Inc. 07 Jun 2021 1 $0 4 Director 09 Jun 2021, 18:22